5-dimethylamiloride has been researched along with ng-nitroarginine methyl ester in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gunawardana, SC; Head, WS; Piston, DW | 1 |
Matsuzaki, T; Okamoto, H; Sasahara, T; Tsutsui, M; Yayama, K | 1 |
2 other study(ies) available for 5-dimethylamiloride and ng-nitroarginine methyl ester
Article | Year |
---|---|
Dimethyl amiloride improves glucose homeostasis in mouse models of type 2 diabetes.
Topics: Amiloride; Amino Acids, Cyclic; Animals; Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Synergism; Homeostasis; Hydrogen-Ion Concentration; Insulin; Insulin Secretion; Insulin-Secreting Cells; Keto Acids; Ketoglutarate Dehydrogenase Complex; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type I; Sodium-Calcium Exchanger | 2008 |
Na(+)/H(+) exchanger inhibitor induces vasorelaxation through nitric oxide production in endothelial cells via intracellular acidification-associated Ca2(+) mobilization.
Topics: Amiloride; Animals; Aorta, Thoracic; Calcium; Calmodulin; Cattle; Endoplasmic Reticulum; Endothelial Cells; Guanidines; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Sodium-Hydrogen Exchangers; Sulfones; Vasodilation | 2013 |